Regulation of distinct pools of amyloid β-protein by multiple cellular proteases

Alzheimer's Research and Therapy

Volumn 5, Issue 4, 2013, Pages

  Leissring, Malcolm A ^a   Turner, Anthony J ^b  

^a MAYO GRADUATE SCHOOL   (United States)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; CARBOXYPEPTIDASE; CATHEPSIN B; CATHEPSIN D; INSULINASE; PROTEINASE;

ALZHEIMER DISEASE; APOPTOSIS; BRAIN REGION; CATABOLISM; CELLULAR DISTRIBUTION; CROSS REACTION; ENDOPLASMIC RETICULUM; ENDOSOME; ENZYME DEGRADATION; EXTRACELLULAR SPACE; GENE DELETION; GENETIC RISK; HUMAN; LYSOSOME; MOLECULAR PATHOLOGY; NERVE DEGENERATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVIEW; TRANSCYTOSIS;

EID: 84887979412     PISSN: None     EISSN: 17589193     Source Type: Journal    
DOI: 10.1186/alzrt194     Document Type: Review

References (49)

1. The origins of Alzheimer disease: a is for amyloid. Selkoe DJ, JAMA 2000 283 1615 1617 10.1001/jama.283.12.1615 10735401 (Pubitemid 30161520)
2. The secretases: enzymes with therapeutic potential in Alzheimer disease. De Strooper B, Vassar R, Golde T, Nat Rev Neurol 2010 6 99 107 10.1038/nrneurol.2009.218 20139999
3. Beta-Secretase, APP and Abeta in Alzheimer's disease. Vassar R, Subcell Biochem 2005 38 79 103 10.1007/0-387-23226-5-4 15709474
4. Translating cell biology into therapeutic advances in Alzheimer's disease. Selkoe DJ, Nature 1999 399 23 A31 10392577
5. Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration. Walsh DM, Selkoe DJ, Protein Pept Lett 2004 11 213 228 10.2174/0929866043407174 15182223 (Pubitemid 38689025)
6. Additive effects of PS1 and APP mutations on secretion of the 42-residue amyloid beta-protein. Citron M, Eckman CB, Diehl TS, Corcoran C, Ostaszewski BL, Xia W, Levesque G, St George Hyslop P, Younkin SG, Selkoe DJ, Neurobiol Dis 1998 5 107 116 10.1006/nbdi.1998.0183 9746908 (Pubitemid 28430721)
7. Abeta-generating enzymes: recent advances in beta- and gamma-secretase research. Vassar R, Citron M, Neuron 2000 27 419 422 10.1016/S0896-6273(00) 00051-9 11055423
8. Proteolytic degradation of amyloid beta-protein. Saido T, Leissring MA, Cold Spring Harb Perspect Med 2012 2 006379 10.1101/cshperspect.a006379 22675659
9. Brain regional correlation of amyloid-beta with synapses and apolipoprotein E in non-demented individuals: potential mechanisms underlying regional vulnerability to amyloid-beta accumulation. Shinohara M, Petersen RC, Dickson DW, Bu G, Acta Neuropathol 2013 125 535 547 10.1007/s00401-013-1086-9 23371365
10. The transcriptionally active amyloid precursor protein (APP) intracellular domain is preferentially produced from the 695 isoform of APP in a {beta}-secretase-dependent pathway. Belyaev ND, Kellett KA, Beckett C, Makova NZ, Revett TJ, Nalivaeva NN, Hooper NM, Turner AJ, J Biol Chem 2010 285 41443 41454 10.1074/jbc.M110.141390 20961856
11. Trafficking of cell surface beta-amyloid precursor protein: retrograde and transcytotic transport in cultured neurons. Yamazaki T, Selkoe DJ, Koo EH, J Cell Biol 1995 129 431 442 10.1083/jcb.129.2.431 7721945
12. Processing of beta-amyloid precursor protein in microglia and astrocytes favors an internal localization over constitutive secretion. Haass C, Hung AY, Selkoe DJ, J Neurosci 1991 11 3783 3793 1744690
13. Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells. Busciglio J, Gabuzda DH, Matsudaira P, Yankner BA, Proc Natl Acad Sci U S A 1993 90 2092 2096 10.1073/pnas.90.5.2092 8446635 (Pubitemid 23070004)
14. Amyloid precursor protein trafficking, processing, and function. Thinakaran G, Koo EH, J Biol Chem 2008 283 29615 29619 10.1074/jbc.R800019200 18650430
15. Gamma-secretase exists on the plasma membrane as an intact complex that accepts substrates and effects intramembrane cleavage. Chyung JH, Raper DM, Selkoe DJ, J Biol Chem 2005 280 4383 4392 15569674 (Pubitemid 40288602)
16. Intraneuronal Abeta42 accumulation in human brain. Gouras GK, Tsai J, Naslund J, Vincent B, Edgar M, Checler F, Greenfield JP, Haroutunian V, Buxbaum JD, Xu H, Greengard P, Relkin NR, Am J Pathol 2000 156 15 20 10.1016/S0002-9440(10)64700-1 10623648 (Pubitemid 30644433)
17. Intracellular amyloid-beta in Alzheimer's disease. LaFerla FM, Green KN, Oddo S, Nat Rev Neurosci 2007 8 499 509 10.1038/nrn2168 17551515 (Pubitemid 46985362)
18. Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease. Glabe C, J Mol Neurosci 2001 17 137 145 10.1385/JMN:17:2:137 11816787 (Pubitemid 33063518)
19. New insights in the amyloid-Beta interaction with mitochondria. Spuch C, Ortolano S, Navarro C, J Aging Res 2012 2012 324968 22523685
20. Nicastrin, presenilin, APH-1, and PEN-2 form active gamma-secretase complexes in mitochondria. Hansson CA, Frykman S, Farmery MR, Tjernberg LO, Nilsberth C, Pursglove SE, Ito A, Winblad B, Cowburn RF, Thyberg J, Ankarcrona M, J Biol Chem 2004 279 51654 51660 10.1074/jbc.M404500200 15456764 (Pubitemid 40017916)
21. Mitochondrial gamma-secretase participates in the metabolism of mitochondria-associated amyloid precursor protein. Pavlov PF, Wiehager B, Sakai J, Frykman S, Behbahani H, Winblad B, Ankarcrona M, Faseb J 2011 25 78 88 10.1096/fj.10-157230 20833873
22. Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Abeta1-42 pathogenesis. Yang AJ, Chandswangbhuvana D, Margol L, Glabe CG, J Neurosci Res 1998 52 691 698 10.1002/(SICI)1097-4547(19980615)52:6<691: :AID-JNR8>3.0.CO;2-3 9669318 (Pubitemid 28300049)
23. Endoplasmic reticulum-localized amyloid beta-peptide is degraded in the cytosol by two distinct degradation pathways. Schmitz A, Schneider A, Kummer MP, Herzog V, Traffic 2004 5 89 101 10.1111/j.1600-0854.2004.00159.x 14690498 (Pubitemid 38196021)
24. Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons. Zhang Y, McLaughlin R, Goodyer C, LeBlanc A, J Cell Biol 2002 156 519 529 10.1083/jcb.200110119 11815632 (Pubitemid 34839899)
25. Cytosolic amyloid-beta peptide 42 escaping from degradation induces cell death. Lee EK, Park YW, Shin DY, Mook-Jung I, Yoo YJ, Biochem Biophys Res Commun 2006 344 471 477 10.1016/j.bbrc.2006.03.166 16630565
26. Cerebrovascular transport of Alzheimer's amyloid beta and apolipoproteins J and E: possible anti-amyloidogenic role of the blood-brain barrier. Zlokovic BV, Life Sci 1996 59 1483 1497 10.1016/0024-3205(96)00310-4 8890929 (Pubitemid 26358266)
27. Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy. Bu G, Nat Rev Neurosci 2009 10 333 344 10.1038/nrn2620 19339974
28. Investigation of 15 of the top candidate genes for late-onset Alzheimer's disease. Belbin O, Carrasquillo MM, Crump M, Culley OJ, Hunter TA, Ma L, Bisceglio G, Zou F, Allen M, Dickson DW, Graff-Radford NR, Petersen RC, Morgan K, Younkin SG, Hum Genet 2011 129 273 282 10.1007/s00439-010-0924-2 21132329
29. Proteolytic degradation of the amyloid beta-protein: the forgotten side of Alzheimer's disease. Leissring MA, Curr Alzheimer Res 2006 3 431 435 10.2174/156720506779025206 17168642 (Pubitemid 46066422)
30. Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer's disease? Nalivaeva NN, Beckett C, Belyaev ND, Turner AJ, J Neurochem 2012 120 167 185 22122230
31. Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease. Mueller-Steiner S, Zhou Y, Arai H, Roberson ED, Sun B, Chen J, Wang X, Yu G, Esposito L, Mucke L, Gan L, Neuron 2006 51 703 714 10.1016/j.neuron.2006.07.027 16982417 (Pubitemid 44374903)
32. Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta(1-42)) to Abeta(1-40), and its inhibition enhances brain Abeta deposition. Zou K, Yamaguchi H, Akatsu H, Sakamoto T, Ko M, Mizoguchi K, Gong JS, Yu W, Yamamoto T, Kosaka K, Yanagisawa K, Michikawa M, J Neurosci 2007 27 8628 8635 10.1523/JNEUROSCI.1549-07.2007 17687040 (Pubitemid 47254272)
33. Cathepsin D selectively degrades Aβ42 and tau: implications for Alzheimer disease pathogenesis. Leissring MA, Reinstatler L, Sahara T, Roman R, Sevlever D, Saftig P, Levites Y, Golde TE, Burgess JD, Ertekin-Taner N, Eckman EA, Society for Neuroscience Chicago, IL: Society for Neuroscience 2009 Program No. 139.108
34. Overlapping profiles of Abeta peptides in the Alzheimer's disease and pathological aging brains. Moore BD, Chakrabarty P, Levites Y, Kukar TL, Baine AM, Moroni T, Ladd TB, Das P, Dickson DW, Golde TE, Alzheimers Res Ther 2012 4 18 10.1186/alzrt121 22621179
35. Deciphering the molecular basis of memory failure in Alzheimer's disease. Walsh DM, Selkoe DJ, Neuron 2004 44 181 193 10.1016/j.neuron.2004.09.010 15450169 (Pubitemid 39348839)
36. Amyloid protein and neurofibrillary tangles coexist in the same neuron in Alzheimer disease. Grundke-Iqbal I, Iqbal K, George L, Tung YC, Kim KS, Wisniewski HM, Proc Natl Acad Sci U S A 1989 86 2853 2857 10.1073/pnas.86.8.2853 2649895 (Pubitemid 19112638)
37. Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome. Gyure KA, Durham R, Stewart WF, Smialek JE, Troncoso JC, Arch Pathol Lab Med 2001 125 489 492 11260621 (Pubitemid 32291552)
38. The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice. LaFerla FM, Tinkle BT, Bieberich CJ, Haudenschild CC, Jay G, Nat Genet 1995 9 21 30 10.1038/ng0195-21 7704018
39. Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. McGowan E, Pickford F, Kim J, Onstead L, Eriksen J, Yu C, Skipper L, Murphy MP, Beard J, Das P, Jansen K, Delucia M, Lin WL, Dolios G, Wang R, Eckman CB, Dickson DW, Hutton M, Hardy J, Golde T, Neuron 2005 47 191 199 10.1016/j.neuron.2005.06.030 16039562 (Pubitemid 41019251)
40. Expression of BRI-amyloid beta peptide fusion proteins: a novel method for specific high-level expression of amyloid beta peptides. Lewis PA, Piper S, Baker M, Onstead L, Murphy MP, Hardy J, Wang R, McGowan E, Golde TE, Biochim Biophys Acta 2001 1537 58 62 10.1016/S0925-4439(01)00054-0 11476963 (Pubitemid 32710040)
41. Differential effects of proteases involved in intracellular degradation of amyloid beta-protein between detergent-soluble and -insoluble pools in CHO-695 cells. Sudoh S, Frosch MP, Wolf BA, Biochemistry 2002 41 1091 1099 10.1021/bi011193l 11802707 (Pubitemid 34083761)
42. Effects of neprilysin chimeric proteins targeted to subcellular compartments on amyloid beta peptide clearance in primary neurons. Hama E, Shirotani K, Iwata N, Saido TC, J Biol Chem 2004 279 30259 30264 10.1074/jbc.M401891200 15100223 (Pubitemid 38937952)
43. Human neprilysin-2 (NEP2) and NEP display distinct subcellular localisations and substrate preferences. Whyteside AR, Turner AJ, FEBS Lett 2008 582 2382 2386 10.1016/j.febslet.2008.05.046 18539150
44. Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Leissring MA, Farris W, Chang AY, Walsh DM, Wu X, Sun X, Frosch MP, Selkoe DJ, Neuron 2003 40 1087 1093 10.1016/S0896-6273(03)00787-6 14687544 (Pubitemid 38032786)
45. The AβCs of Aβ-cleaving proteases. Leissring MA, J Biol Chem 2008 283 29645 29649 10.1074/jbc.R800022200 18723506
46. Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy. Farris W, Schutz SG, Cirrito JR, Shankar GM, Sun X, George A, Leissring MA, Walsh DM, Qiu WQ, Holtzman DM, Selkoe DJ, Am J Pathol 2007 171 241 251 10.2353/ajpath.2007.070105 17591969 (Pubitemid 47339241)
47. Neprilysin-sensitive synapse-associated amyloid-beta peptide oligomers impair neuronal plasticity and cognitive function. Huang SM, Mouri A, Kokubo H, Nakajima R, Suemoto T, Higuchi M, Staufenbiel M, Noda Y, Yamaguchi H, Nabeshima T, Saido TC, Iwata N, J Biol Chem 2006 281 17941 17951 10.1074/jbc.M601372200 16636059 (Pubitemid 44035593)
48. Degradation of Alzheimer's beta-amyloid protein by human cathepsin D. McDermott JR, Gibson AM, Neuroreport 1996 7 2163 2166 10.1097/00001756- 199609020-00021 8930981 (Pubitemid 26361838)
49. Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells. Saftig P, Hetman M, Schmahl W, Weber K, Heine L, Mossmann H, Koster A, Hess B, Evers M, von Figura K, Peters C, Embo J 1995 14 3599 3608 7641679